Sustainable biomedical device for use in regenerative medicine

soy
Credit: CC0 Public Domain

UPV/EHU researchers have developed a biomedical device consisting of byproducts from the food industry and which displays excellent properties for use in regenerative medicine. The novel device comprises soy protein and chitin, which form a matrix with a porous, interconnected microarchitecture similar to that of certain body tissues. The work has been published in the June issue of Green Chemistry.

Added to the growing need to develop new therapies for is the social requirement to be environmentally friendly. In this respect, the group of researchers has shown that natural byproducts from the food industry, normally discarded in , could be an excellent source of biomaterials for producing biomedical devices.

"It is important to point out that to date, no one has exploited the potential in displayed by soy protein and chitin blended in a microporous matrix," the researchers write. "As the first milestone in this respect, this incorporates two natural components obtained from the , thus contributing toward the widely called-for social requirement to upgrade waste from production on an industrial level.

The device has also displayed some physico-chemical and mechanical properties suitable for applications in regenerative medicine. What is more, it has also been found to be totally biocompatible, not only in in vitro cell lines, but also in an in vivo murine model. Finally, we have confirmed that this device is capable of hosting a large number of viable stem cells inside it, thus increasing its level of bioactive compound secretion and displaying its potential as a very effective vehicle in cell therapy."

This biotechnological approach may have a potentially successful application in the matrix-based regenerative medicine industry. These devices capable of hosting stem cells are destined to be the revolution, not only in but also in everyday clinical practice. "Clinical scenarios as complex as chronic injuries or bone problems need a multifocal approach which combines bioactive matrices with biological agents having regenerative effects," they concluded.


Explore further

New research into stem cell mutations could improve regenerative medicine

More information: Kevin Las Heras et al. Soy protein and chitin sponge-like scaffolds: from natural by-products to cell delivery systems for biomedical applications, Green Chemistry (2020). DOI: 10.1039/D0GC00089B
Journal information: Green Chemistry

Citation: Sustainable biomedical device for use in regenerative medicine (2020, July 1) retrieved 10 August 2020 from https://phys.org/news/2020-07-sustainable-biomedical-device-regenerative-medicine.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
11 shares

Feedback to editors

User comments